Does airduo cause oral thrush in some users?

Do some people get oral thrush while using AirDuo?

AirDuo combines fluticasone, an inhaled corticosteroid, and salmeterol, a long-acting beta-agonist. The corticosteroid portion can suppress local immune activity in the mouth and throat, allowing Candida species to overgrow and produce thrush.

How common is oral thrush with AirDuo?

Clinical trial data listed in the prescribing information report oral candidiasis in roughly 1–3 percent of patients. Real-world use may show higher rates because many users do not rinse their mouth after each dose.

Why does inhaled fluticasone promote thrush?

Fluticasone particles deposit on the oral mucosa. The drug reduces local inflammation but also lowers mucosal resistance to fungal colonization. Salmeterol itself does not appear to increase fungal risk.

Can rinsing lower the chance of thrush?

Rinsing the mouth with water and spitting after each inhalation reduces drug residue on the mucosa and cuts reported thrush rates. Denture wearers and people who use the inhaler twice daily should rinse especially carefully.

What other factors raise the risk?

Concurrent use of antibiotics, poorly controlled diabetes, smoking, and high-dose or frequent steroid exposure each increase the likelihood of developing oral candidiasis during AirDuo treatment.

How is thrush treated if it appears?

Most cases respond to topical antifungal agents such as nystatin suspension or clotrimazole lozenges. Severe or recurrent infections may require a short course of oral fluconazole. Patients usually continue AirDuo while treating the infection, provided they improve their rinsing technique.

When should a patient contact a doctor about possible thrush?

White patches on the tongue or inner cheeks, soreness, or altered taste that persist beyond a few days warrant a call to the prescriber. Early treatment prevents spreading to the esophagus.

Does switching inhalers reduce thrush risk?

Inhalers with lower oropharyngeal deposition, such as certain dry-powder budesonide devices, sometimes produce fewer local fungal infections. Any switch should be discussed with the prescribing clinician to maintain asthma control.

When does the patent on AirDuo expire?

Teva’s U.S. composition-of-matter patent for the fluticasone-salmeterol dry-powder formulation expires in 2026, though other formulation and method patents extend protection into the late 2020s. Generic entry timing remains subject to ongoing litigation.